RESEARCH TRIANGLE PARK, N.C., Aug. 8 /PRNewswire-FirstCall/ -- Icoria,
Inc. (OTCBB: ICOR.OB), announced today that on Monday, August 15 it will
report its 2005 second quarter financial results for the period ending June
30, 2005.
The company's management team will conduct a conference call and webcast
to discuss the results on Tuesday, August 16, at 8:30 a.m. ET. Interested
participants should call 1-800-474-8920 or, for those calling internationally,
719-457-2727. The conference call ID number is 2043271. Icoria encourages
participants to dial in 10 minutes before the call commences.
The webcast can be accessed from Icoria's web site at
http://www.icoria.com by clicking on the Investor Relations link. For those
unable to participate, replays of the call may be heard online at
http://www.icoria.com. Supplemental information will also be available
online.
About Icoria
Icoria, Inc. is a biotechnology company focused on the discovery of novel,
multi-parameter biomarkers using its unique multi-platform approach. Icoria
intends to use these future biomarkers internally to develop multi-analyte
diagnostics to define and grade pathology or disease state with a high level
of specificity and sensitivity, and use its technology to help collaborators
and customers develop better, safer drugs and diagnostics and to identify
targets, leads and drug/diagnostic combinations for liver injury, metabolic
disorders and cancer. Icoria's shares trade on the over the counter bulletin
board.
This press release contains forward-looking statements. Such forward-
looking statements are based on management's current expectations and are
subject to a number of risks, factors and uncertainties that may cause actual
results, events and performance to differ materially from those referred to in
the forward-looking statements. These risks, factors and uncertainties
include, but are not limited to, Icoria's early stage of development, history
of net losses, technological and product development uncertainties, reliance
on research collaborations, uncertainty of additional funding and ability to
protect its patents and proprietary rights. Certain of these and other risks
are identified in Icoria's annual report on Form 10-K for the year ended
December 31, 2004, as filed with the Securities and Exchange Commission. The
Company does not intend to update any of the forward-looking statements after
the date of this release to conform these statements to actual results or to
changes in our expectations, except as may be required by law.
SOURCE Icoria, Inc.
 back to top
Related links:
http://www.icoria.com
CONTACT:
Icoria, Inc. Media-Public Relations,
+1-919-425-2999
|
